Regulation of complement activation by C-reactive protein: Targeting of the inhibitory activity of C4b-binding protein

Journal of Immunology

Volumn 176, Issue 12, 2006, Pages 7612-7620

  Sjöberg, Andreas P ^a   Trouw, Leendert A ^a   McGrath, Fabian D G ^b   Hack, C Erik ^b,c   Blom, Anna M ^a  

^a LUND UNIVERSITY   (Sweden)

^b SANQUIN RESEARCH   (Netherlands)

^c VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE PHASE PROTEIN; C REACTIVE PROTEIN; CALCIUM; COMPLEMENT COMPONENT C4B; COMPLEMENT FACTOR H; MONOCLONAL ANTIBODY; PHOSPHORYLCHOLINE; PROTEIN S;

ARTICLE; BETA CHAIN; COMPLEMENT ACTIVATION; COMPLEMENT ALTERNATIVE PATHWAY; COMPLEMENT CLASSICAL PATHWAY; CONTROLLED STUDY; HUMAN; HUMAN CELL; INFLAMMATION; IONIC STRENGTH; PRIORITY JOURNAL; PROTEIN DEGRADATION;

EID: 33744956898     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.176.12.7612     Document Type: Article

References (40)

1. Gigli, I., T. Fujita, and V. Nussenzweig. 1979. Modulation of the classical pathway C3 convertase by plasma protein C4b binding and C3b inactivator. Proc. Natl. Acad. Sci. USA 76: 6596-6600.
2. Scharfstein, J., A. Ferreira, I. Gigli, and V. Nussenzweig. 1978. Human C4b-binding protein, isolation and characterization. J. Exp. Med. 148: 207-222.
3. Blom, A. M., L. Kask, and B. Dahlbäck. 2003. CCP1-4 of the C4b-binding protein α-chain are required for Factor I mediated cleavage of C3b. Mol. Immunol. 39: 547-556.
4. Hourcade, D., M. K. Liszewski, M. Krych-Goldberg, and J. P. Atkinson. 2000. Functional domains, structural variations and pathogen interactions of MCP, DAF and CR1. Immunopharmacology 49: 103-116.
5. Hillarp, A., and B. Dahlbäck. 1988. Novel subunit in C4b-binding protein required for protein S binding. J. Biol. Chem. 263: 12759-12764.
6. Boerger, L. M., P. C. Morris, G. R. Thurnau, E. C. T., and P. C. Comp. 1987. Oral contraceptives and gender affect protein S status. Blood 69: 692-694.
7. Saeki, T., S. Hirose, M. Nukatsuka, Y. Kusunoki, and S. Nagasawa. 1989. Evidence that C4b-binding protein is an acute phase protein. Biochem. Biophys. Res. Commun. 164: 1446-1451.
8. Barnum, S. R., and B. Dahlbäck. 1990. C4b-binding protein, a regulatory component of the classical pathway of complement, is an acute-phase protein and is elevated in systemic lupus erythematosus. Complement Inflamm. 7: 71-77.
9. Criado Garcia, O., P. Sanchez Corral, and S. Rodriguez de Cordoba. 1995. Isoforms of human C4b-binding protein. II. Differential modulation of the C4BPA and C4BPB genes by acute phase cytokines. J. Immunol. 155: 4037-4043.
10. Garcia de Frutos, P., R. I. Alim, Y. Härdig, B. Zöller, and B. Dahlbäck. 1994. Differential regulation of α and β chains of C4b-binding protein during acute-phase response resulting in stable plasma levels of free anticoagulant protein S. Blood 84: 815-822.
11. Black, S., I. Kushner, and D. Samols. 2004. C-reactive Protein. J. Biol. Chem. 279: 48487-48490.
12. Volanakis, J. E. 2001. Human C-reactive protein: expression, structure, and function. Mol. Immunol. 38: 189-197.
13. Wolbink, G. J., M. C. Brouwer, S. Buysmann, I. J. ten Berge, and C. E. Hack. 1996. CRP-mediated activation of complement in vivo: assessment by measuring circulating complement-C-reactive protein complexes. J. Immunol. 157: 473-479.
14. Aronen, M., T. Lehto, and S. Meri. 1992. Regulation of alternative pathway complement activation by an interaction of C-reactive protein with factor H. Immunol. Infect. Dis. 3: 83-87.
15. Jarva, H., T. S. Jokiranta, J. Hellwage, P. F. Zipfel, and S. Meri. 1999. Regulation of complement activation by C-reactive protein: targeting the complement inhibitory activity of factor H by an interaction with short consensus repeat domains 7 and 8-11. J. Immunol. 163: 3957-3962.
16. Dahlbäck, B. 1983. Purification of human C4b-binding protein and formation of its complex with vitamin K-dependent protein S. Biochem. J. 209: 847-856.
17. Tenner, A. J., P. H. Lesavre, and N. R. Cooper. 1981. Purification and radiolabeling of human C1q. J. Immunol. 27: 648-653.
18. Andersson, M., A. Hanson, G. Englund, and B. Dahlbäck. 1991. Inhibition of complement components C3 and C4 by cadralazine and its active metabolite. Eur. J. Clin. Pharmacol. 40:261-265.
19. Crossley, L., and R. Porter. 1980. Purification of the human complement control protein C3b inactivator. Biochem. J. 191: 173-182.
20. Blom, A. M., L. Kask, and B. Dahlbäck. 2001. Structural requirements for the complement regulatory activities of C4BP. J. Biol. Chem. 276: 27136-27144.
21. Kask, L., B. O. Villoutreix, M. Steen, B. Ramesh, B. Dahlback, and A. M. Blom. 2004. Structural stability and heat-induced conformational change of two complement inhibitors: C4b-binding protein and factor H. Protein Sci. 13: 1356-1364.
22. Garcia de Frutos, P., Y. Härdig, and B. Dahlbäck. 1995. Serum amyloid P component binding to C4b-binding protein. J. Biol. Chem. 270: 26950-26955.
23. Padilla, N. D., C. Ciurana, J. van Oers, A. C. Ogilvie, and C. E. Hack. 2004. Levels of natural IgM antibodies against phosphorylcholine in healthy individuals and in patients undergoing isolated limb perfusion. J. Immunol. Methods 293: 1-11.
24. Kask, L, L. Trouw, B. Dahlbäck, and A. M. Blom. 2004. C4b-binding protein-protein S complex inhibits phagocytosis of apoptotic cells. J. Biol. Chem. 279: 23869-23873.
25. Giannakis, E., T. S. Jokiranta, D. A. Male, S. Ranganathan, R. J. Ormsby, V. A. Fischetti, C. Mold, and D. L. Gordon. 2003. A common site within factor H SCR 7 responsible for binding heparin, C-reactive protein and streptococcal M protein. Eur. J. Immunol. 33: 962-969.
26. Thompson, D., M. B. Pepys, and S. P. Wood. 1999. The physiological structure of human C-reactive protein and its complex with phosphocholine. Struct. Fold Des. 7: 169-177.
27. Weiser, J. N., N. Pan, K. L. McGowan, D. Musher, A. Martin, and J. Richards. 1998. Phosphorylcholine on the lipopolysaccharide of Haemophilus influenzae contributes to persistence in the respiratory tract and sensitivity to serum killing mediated by C-reactive protein. J. Exp. Med. 187: 631-640.
28. Garlanda, C., B. Bottazzi, A. Bastone, and A. Mantovani. 2005. Pentraxins at the crossroads between innate immunity, inflammation, matrix deposition, and female fertility. Annu. Rev. Immunol. 23: 337-366.
29. Schwalbe, R. A., B. Dahlback, J. E. Coe, and G. L. Nelsestuen. 1992. Pentraxin family of proteins interact specifically with phosphorylcholine and/or phosphorylethanolamine. Biochemistry 31: 4907-4915.
30. Webb, J. H., A. M. Blom, and B. Dahlbäck. 2003. The binding of protein S and the protein S-C4BP complex to neutrophils is apoptosis-dependent. Blood Coagul. Fibrinolysis 14: 355-359.
31. Trouw, L. A., S. C. Nilsson, I. Goncalves, G. Landberg, and A. M. Blom. 2005. C4b-binding protein binds to necrotic cells and DNA, limiting DNA release and inhibiting complement activation. J. Exp. Med. 201: 1937-1948.
32. Agrawal, A. 2005. CRP after 2004. Mol. Immunol. 42: 927-930.
33. Venugopal, S. K., S. Devaraj, and I. Jialal. 2005. Effect of C-reactive protein on vascular cells: evidence for a proinflammatory, proatherogenic role. Curr. Opin. Nephrol. Hypertens. 14: 33-37.
34. Sun, H., T. Koike, T. Ichikawa, K. Hatakeyama, M. Shiomi, B. Zhang, S. Kitajima, M. Morimoto, T. Watanabe, Y. Asada, Y. E. Chen, and J. Fan. 2005. C-reactive protein in atherosclerotic lesions: its origin and pathophysiological significance. Am. J. Pathol. 167: 1139-1148.
35. Venugopal, S. K., S. Devaraj, and I. Jialal. 2005. Macrophage conditioned medium induces the expression of C-reactive protein in human aortic endothelial cells: potential for paracrine/autocrine effects. Am. J. Pathol. 166: 1265-1271.
36. Niculescu, F., and H. Rus. 2004. The role of complement activation in atherosclerosis. Immunol. Res. 30: 73-80.
37. Jönsson, G., L. Truedsson, G. Sturfelt, V. A. Oxelius, I. H. Braconier, and A. G. Sjöholm. 2005. Hereditary C2 deficiency in Sweden: frequent occurrence of invasive infection, atherosclerosis, and rheumatic disease. Medicine 84: 23-34.
38. Muscari, A., D. Sbano, L. Bastagli, G. Poggiopollini, V. Tomassetti, P. Forti, P. Boni, G. Ravaglia, M. Zoli, and P. Puddu. 2005. Effects of weight loss and risk factor treatment in subjects with elevated senim C3, an inflammatory predictor of myocardial infarction. Int. J. Cardiol. 100: 217-223.
39. Paul, A., E. T. Yeh, and L. Chan. 2005. A proatherogenic role for C-reactive protein in vivo. Curr. Opin. Lipidol. 16: 512-517.
40. Li, S. H., P. E. Szmitko, R. D. Weisel, C. H. Wang, P. W. Fedak, R. K. Li, D. A. Mickle, and S. Verma. 2004. C-reactive protein upregulates complement-inhibitory factors in endothelial cells. Circulation 109: 833-836.